quillaia
soapbark
Identification
| Name | quillaia |
| IUPAC | quillaja saponaria molina |
| CAS Number | 977002-27-9 |
| FDA UNII | Search |
Regulatory
| FDA Mainterm (SATF) | 977002-27-9 ; QUILLAIA (QUILLAJA SAPONARIA MOLINA) |
| FDA Regulation | FDA PART 172 -- FOOD ADDITIVES PERMITTED FOR DIRECT ADDITION TO FOOD FOR HUMAN CONSUMPTION |
Physical Properties
| Food Chemicals Codex Listed | No |
No sensory data available
Safety Information
| Oral/Parenteral Toxicity | Not determined |
| Dermal Toxicity | Not determined |
| Inhalation Toxicity | Not determined |
GHS Classification
['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']
Safety in Use
| Category | spices, other natural seasonings and flavorings |
| Recommendation for quillaia usage levels up to | not for fragrance use. |
| Recommendation for quillaia flavor usage levels up to | not for flavor use. |
No supplier data available
Potential Uses
Natural Occurrence
Synonyms
quillaja saponaria molina
soapbark
PubMed:
Electrophoretic mobility as a tool to separate immune adjuvant saponins from Quillaja saponaria Molina.
PubMed:
Phenolic constituents in commercial aqueous Quillaja (Quillaja saponaria Molina) wood extracts.
PubMed:
Influence of Quil A on liposomal membranes.
PubMed:
In vivo delivery of bovine viral diahorrea virus, E2 protein using hollow mesoporous silica nanoparticles.
PubMed:
Interaction of Quillaja bark saponins with food-relevant proteins.
PubMed:
Unusual penetration of phospholipid mono- and bilayers by Quillaja bark saponin biosurfactant.
PubMed:
Mesoporous silica nanoparticles act as a self-adjuvant for ovalbumin model antigen in mice.
PubMed:
Effects of saponin extracts on air emissions from steers.
PubMed:
Electrospray ionization ion-trap multiple-stage mass spectrometry of Quillaja saponins.
PubMed:
Characterization of in vivo anti-rotavirus activities of saponin extracts from Quillaja saponaria Molina.
PubMed:
Ultrasonically enhanced extraction of bioactive principles from Quillaja Saponaria Molina.
PubMed:
Prevention of rotavirus infections in vitro with aqueous extracts of Quillaja Saponaria Molina.
PubMed:
Nanoparticulate Quillaja saponin induces apoptosis in human leukemia cell lines with a high therapeutic index.
PubMed:
Multidimensional profiling of components in complex mixtures of natural products for metabolic analysis, proof of concept: application to Quillaja saponins.
PubMed:
Advances in saponin-based adjuvants.
PubMed:
Structural classification of acyl-substituted Quillaja saponins by electrospray ionisation ion trap multiple-stage mass spectrometry in combination with multivariate analysis.
PubMed:
Antiviral activity obtained from aqueous extracts of the Chilean soapbark tree (Quillaja saponaria Molina).
PubMed:
Saponins from Quillaja saponaria Molina: isolation, characterization and ability to form immuno stimulatory complexes (ISCOMs).
PubMed:
Assessment of the monoterpene, glycidic and triterpene-moieties' contributions to the adjuvant function of the CP05 saponin of Calliandra pulcherrima Benth during vaccination against experimental visceral leishmaniasis.
PubMed:
Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis.
PubMed:
Exposure of tilapia pituitary cells to saponins: insight into their mechanism of action.
PubMed:
Pulcherrimasaponin, from the leaves of Calliandra pulcherrima, as adjuvant for immunization in the murine model of visceral leishmaniasis.
PubMed:
Metabolomic analysis of saponins in crude extracts of Quillaja saponaria by liquid chromatography/mass spectrometry for product authentication.
PubMed:
Oligosaccharide sequences in Quillaja saponins by electrospray ionization ion trap multiple-stage mass spectrometry.
PubMed:
Solid-phase extraction NMR studies of chromatographic fractions of saponins from Quillaja saponaria.
PubMed:
Degradation of Quillaja saponaria Molina saponins: loss of the protective effects of a herpes simplex virus 1 subunit vaccine.
PubMed:
QS-21 structure/function studies: effect of acylation on adjuvant activity.
PubMed:
Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins.
PubMed:
Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunity.
PubMed:
Structural studies of triterpenoid saponins with new acyl components from Quillaja saponaria Molina.
PubMed:
Novel acetylated triterpenoid saponins in a chromatographic fraction from Quillaja saponaria Molina.
PubMed:
Characterization of some O-acetylated saponins from Quillaja saponaria Molina.
PubMed:
Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity.
PubMed:
Uptake and adjuvant activity of orally delivered saponin and ISCOM vaccines.
PubMed:
ISCOMs and other saponin based adjuvants.
PubMed:
Triterpenoid saponins containing an acetylated branched D-fucosyl residue from Quillaja saponaria Molina.
PubMed:
Separation and structural analysis of some saponins from Quillaja saponaria Molina.
PubMed:
Preparation and characterisation of quillaja saponin with less heterogeneity than Quil-A.
PubMed:
Separation and structural analysis of saponins in a bark extract from Quillaja saponaria Molina.
PubMed:
ISCOMs: an adjuvant with multiple functions.
PubMed:
Triterpenoid saponins from Quillaja saponaria.
PubMed:
QS-21 and QS-7: purified saponin adjuvants.
PubMed:
Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicity.
PubMed:
In vivo and in vitro induction of IL-6 by Quillaja saponaria molina triterpenoid formulations.
PubMed:
In vitro activation of antigen-presenting cells (APC) by defined composition of Quillaja saponaria Molina triterpenoids.
PubMed:
Structure of the saponin adjuvant QS-21 and its base-catalyzed isomerization product by 1H and natural abundance 13C NMR spectroscopy.
PubMed:
Molecular structures of saponins from Quillaja saponaria Molina.
PubMed:
Isomerization and formulation stability of the vaccine adjuvant QS-21.
PubMed:
A semisynthetic Quillaja saponin as a drug delivery agent for aminoglycoside antibiotics.
PubMed:
Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscoms.
PubMed:
A 4-methyl-7-hydroxyphthalide glycoside and other constituents from Quillaja saponaria molina.
PubMed:
Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix.
PubMed:
Effect of saponin from Quillaja saponaria (molina) on antibody, tumour necrosis factor and interferon-gamma production.
PubMed:
Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccines.
PubMed:
Glycosyl compositions and structural characteristics of the potential immuno-adjuvant active saponins in the Quillaja saponaria Molina extract quil A.
PubMed:
Development of a genetically engineered vaccine against feline leukemia virus infection.
PubMed:
Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex.
PubMed:
Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.
PubMed:
Saponin adjuvants. 3. Isolation of a substance from Quillaja saponaria Molina with adjuvant activity in food-and-mouth disease vaccines.